by David Rosado | Nov 26, 2018 | Blog
An experimental peanut allergy treatment is ready for U.S. Food and Drug Administration review. According to research published in The New England Journal of Medicine, A phase three trial included 551 people, most ages 4 to 17 with a history of life-threatening...
